pyridoxal phosphate has been researched along with ST Elevated Myocardial Infarction in 1 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karlsson, JE | 1 |
| El-Saadi, W | 1 |
| Ali, M | 1 |
| Puskar, W | 1 |
| Skogvard, P | 1 |
| Engvall, JE | 1 |
| Andersson, RG | 1 |
| Maret, E | 1 |
| Jynge, P | 1 |
1 trial available for pyridoxal phosphate and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
Topics: Dose-Response Relationship, Drug; Edetic Acid; Feasibility Studies; Female; Follow-Up Studies; Heart | 2015 |